Higher
levels of a certain fat within the bloodstream called ceramides may increase an
individual's risk of establishing Alzheimer's disease, based on a study posted
within the July 18, 2012, online concern about Neurology, the medical journal
of the American Academy of Neurology.
Regarding
the study, 99 females related to the ages of 70 and 79 and free of dementia in
the Women's Health and Aging Study II had their own blood tested for quantities
of serum ceramides, a fatty compound found through the entire body that is
linked to inflammation and cell death. The individuals were absolutely placed
into three groups: high, middle and low levels of ceramides. These were then
followed for approximately nine years. As to the 99 individuals, 27 developed
dementia and 18 patients were really diagnosed with probable Alzheimer's
disease.
The
research found that women who exactly had the highest quantities of the
biomarker were 10 times very likely to develop Alzheimer's disease compared to
ladies with the lowest stages. Those particular with middle stages of the
biomarker were nearly eight times very likely to develop the disorder compared
to those considering the lowest levels.
"These
bits of information are very important as identifying a dependable biomarker
for earlier Alzheimer's which needs little charge and inconvenience in an
affected individual could help modify our center of attention from handling the
disorder to actually preventing or delaying it," said Valory Pavlik, PhD,
with the Alzheimer's Disease and Memory Disorders Center of Baylor College of
Medicine in Houston as well as a membership owner the American Academy of
Neurology, inside an accompanying editorial.
No comments:
Post a Comment